Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4
- 30 September 2011
- journal article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 18 (5) , 578-586
Abstract
Background: Antibodies to aquaporin-4 (AQP4-Ab), known as NMO-IgG, are a sensitive and specific marker for neuromyelitis optica (NMO).Keywords
This publication has 28 references indexed in Scilit:
- No relapse of neuromyelitis optica during drug-induced B-lymphopenia with hypogammaglobulinemiaNeurology, 2010
- EFNS guidelines on diagnosis and management of neuromyelitis opticaEuropean Journal of Neurology, 2010
- Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis opticaMultiple Sclerosis Journal, 2008
- Antibody to aquaporin-4 in the long-term course of neuromyelitis opticaBrain, 2008
- NMO-IgG predicts the outcome of recurrent optic neuritisNeurology, 2008
- Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titreBrain, 2007
- Diagnosis and Treatment of Neuromyelitis OpticaThe Neurologist, 2007
- Revised diagnostic criteria for neuromyelitis opticaNeurology, 2006
- Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitisAnnals of Neurology, 2006
- A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosisThe Lancet, 2004